[Potential value of 5-HT2 receptor antagonists in the treatment of dysthymic disorders].
Sechter
D
D
Service de Psychiatrie et Psychologie Médicale, C.H.U. Saint-Jacques, Besançon.
Bonin
B
B
Bizouard
P
P
D000818:Animals; D001008:Anxiety Disorders / Q000188:drug therapy / Q000503:physiopathology; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D011985:Receptors, Serotonin / Q000502:physiology; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D011985:Receptors, Serotonin; D012702:Serotonin Antagonists
Intérêt potential des antagonistes des récepteurs 5-HT2 dans le traitement des dysthymies.